Literature DB >> 28684935

The Role of Temporary Fecal Diversion.

Amy L Lightner1, John H Pemberton1.   

Abstract

The use of temporary fecal diversion is of great importance to tenuous anastomosis, immunosuppressed patient, or actively infected patient. Its use protects newly constructed intestinal anastomoses from being the culprit of pelvic sepsis or systemic illness. Thus, potential morbidity and mortality can be averted. However, its appropriate or optimal use is often debated. We herein discuss the evidence for when to best use a diverting stoma for colorectal, coloanal, and ileoanal anastomoses. We also discuss the importance of considering a temporary diverting stoma in the setting of high-dose immunosuppression (e.g., transplant patients or inflammatory bowel disease), active infection, or upon creation of ileal pouch-anal anastomosis. Lastly, we discuss the advantages and disadvantages of a loop ileostomy versus colostomy for temporary diversion of fecal contents.

Entities:  

Keywords:  anastomotic leak; colostomy; diverting ostomy; loop ileostomy; stoma

Year:  2017        PMID: 28684935      PMCID: PMC5498160          DOI: 10.1055/s-0037-1598158

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  76 in total

1.  Predicting the risk of anastomotic leakage in left-sided colorectal surgery using a colon leakage score.

Authors:  Jan Willem T Dekker; Gerrit Jan Liefers; Johan C A de Mol van Otterloo; Hein Putter; Rob A E M Tollenaar
Journal:  J Surg Res       Date:  2010-12-01       Impact factor: 2.192

2.  Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance.

Authors:  Tsuyoshi Konishi; Toshiaki Watanabe; Junji Kishimoto; Hirokazu Nagawa
Journal:  J Am Coll Surg       Date:  2006-01-04       Impact factor: 6.113

3.  Diverting stoma after low anterior resection: more arguments in favor.

Authors:  Alexis B Ulrich; Christoph Seiler; Nuh Rahbari; Jürgen Weitz; Markus W Büchler
Journal:  Dis Colon Rectum       Date:  2009-03       Impact factor: 4.585

4.  Long-term results of ileorectal anastomosis in ulcerative colitis in Stockholm County.

Authors:  C E Leijonmarck; R Löfberg; A Ost; G Hellers
Journal:  Dis Colon Rectum       Date:  1990-03       Impact factor: 4.585

5.  Proctocolectomy without ileostomy for ulcerative colitis.

Authors:  A G Parks; R J Nicholls
Journal:  Br Med J       Date:  1978-07-08

6.  What is the risk for a permanent stoma after low anterior resection of the rectum for cancer? A six-year follow-up of a multicenter trial.

Authors:  Rickard Lindgren; Olof Hallböök; Jörgen Rutegård; Rune Sjödahl; Peter Matthiessen
Journal:  Dis Colon Rectum       Date:  2011-01       Impact factor: 4.585

7.  Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease.

Authors:  Mukta K Krane; Marco E Allaix; Marco Zoccali; Konstantin Umanskiy; Michele A Rubin; Anthony Villa; Roger D Hurst; Alessandro Fichera
Journal:  Dis Colon Rectum       Date:  2013-04       Impact factor: 4.585

8.  Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.

Authors:  Chelliah R Selvasekar; Robert R Cima; David W Larson; Eric J Dozois; Jeffrey R Harrington; William S Harmsen; Edward V Loftus; William J Sandborn; Bruce G Wolff; John H Pemberton
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

9.  Long-term results of salvage surgery for septic complications after restorative proctocolectomy: does fecal diversion improve outcome?

Authors:  Stephen R Gorfine; Alessandro Fichera; Michael T Harris; Joel J Bauer
Journal:  Dis Colon Rectum       Date:  2003-10       Impact factor: 4.585

10.  Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery.

Authors:  Liliana Bordeianou; Hiroko Kunitake; Paul Shellito; Richard Hodin
Journal:  Int J Colorectal Dis       Date:  2009-10-02       Impact factor: 2.571

View more
  7 in total

1.  Journey for patients following ileostomy creation is not straightforward.

Authors:  Dedrick Kok Hong Chan; Jingyu Ng; Frederick Hong-Xiang Koh; Tianzhi Lim; Danson Yeo; Kok-Yang Tan; Ker-Kan Tan
Journal:  Int J Colorectal Dis       Date:  2019-11-09       Impact factor: 2.571

Review 2.  Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It?

Authors:  Maitham A Moslim; Amir L Bastawrous; D Rohan Jeyarajah
Journal:  J Gastrointest Surg       Date:  2021-06-07       Impact factor: 3.452

3.  Skin bridge loop stoma: outcome in 45 patients in comparison with stoma made on a plastic rod.

Authors:  Filippo Carannante; Gianluca Mascianà; Sara Lauricella; Marco Caricato; Gabriella Teresa Capolupo
Journal:  Int J Colorectal Dis       Date:  2019-11-16       Impact factor: 2.571

4.  Minimally invasive approach to low-velocity penetrating extraperitoneal rectal trauma.

Authors:  Megan Melland-Smith; Tyler R Chesney; Shady Ashamalla; Fred Brenneman
Journal:  Trauma Surg Acute Care Open       Date:  2020-05-12

5.  Laparoscopic Versus Open Sigmoid Loop Colostomy: A Comparative Study from a Cohort of 62 Patients Requiring Temporary Faecal Diversion at a Tertiary Care Center in North India.

Authors:  Navjot Singh; Parvez David Haque; Shekhar Upadhyay; Navneet Kumar Chaudhry
Journal:  Niger J Surg       Date:  2019 Jul-Dec

6.  Predictors of dehydration and acute renal failure in patients with diverting loop ileostomy creation after colorectal surgery.

Authors:  Omar Vergara-Fernández; Mario Trejo-Avila; Oscar Santes; Danilo Solórzano-Vicuña; Noel Salgado-Nesme
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

7.  Effects of fecal stream deprivation on human intestinal barrier after loop ileostomy.

Authors:  Xiaolong Li; Haitao Ma; Yiming Sun; Teming Li; Cheng Wang; Hong Zheng; Guoqing Chen; Guangsheng Du; Guangyan Ji; Hua Yang; Weidong Xiao; Yuan Qiu
Journal:  J Gastroenterol Hepatol       Date:  2022-04-26       Impact factor: 4.369

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.